Martin W H Wong

Call 2004 (Hong Kong), 2005 (New York), 2019 (New South Wales)


English, Cantonese, Mandarin


T: +852 2840 1130

Secretary: Ms. Kit Lai


Martin has an extensive practice in civil litigation (in all levels of Courts and Tribunals in Hong Kong) and arbitration, particularly in cross-border commercial disputes involving financing, investment, JVs etc..  He also has an established practice in matters such as equal opportunity, professional negligence and personal injuries.  He has also advised on regulatory matters for intended listed companies and acted as expert on matters of Hong Kong law in court litigation and arbitration in the Mainland, Malaysia and Singapore.

He also has significant experience in acting in urgent matters such as obtaining injunctions in major commercial disputes.

Apart from English, he has conducted hearings in Punti and Mandarin and supplied written submissions in Chinese.

Martin was appointed as Deputy District Judge in March 2018, November 2022 and Temporary Deputy Registrar of the High Court in January 2019, November 2020 and March 2022.

Practice Areas

Commercial Law
Company Law
Equal Opportunity
Equity and Trusts
Personal Injuries
Professional Negligence



Boston University


University of Hong Kong


University of Hong Kong
  • Hong Kong Bar Association – Deputy Honorary Secretary
  • Hong Kong Bar Association – Member of the Standing Committee on Discipline
  • The University of Hong Kong – External Examiner for Personal Injury Litigation examination
  • The Chinese University of Hong Kong – External Course Assessor for Personal Injuries Practice course 2021-2024
  • City University of Hong Kong – External Academic Advisor for Personal Injuries Practice course
  • Hong Kong Advocacy Training Council – Vice Chairman
  • The Woo Po Shing Medal in Law (2002)
  • Middle Temple Society Scholarship (2004)


  • Acted for the minority JV partner in the disputes arising from management of the JV in the Mainland (HCA 2165/2020; HCA 702/2021; HCA 150/2022)
  • Acted for the Mainland lender in a claim for Mareva Injunction in aid of Mainland loan recovery action (HCMP 2301/2020)
  • Acted for the for the defendant hospital in a claim for medical negligence resulting in birth defects (HCPI 277/2020)
  • Acted for the defendant doctors in a claim for medical negligence relating to assisted reproductive technology (HCPI 948/2018)
  • Acted for the defendant anaesthetist in a claim for medical negligence resulting in vegetative state (HCPI 899/2017)
  • Acted for the subsidiaries in the disputes in relation to XIO Fund I LP (HCCT 49 & 50/2017)
  • Acted for one of the shareholders in the disputes in relation to Everglory Energy Limited (HCCW 198/2016; HCMP 2735/2016; HCA 1690/2016)
  • Acted for the majority shareholder of China Metal Recycling (Holdings) Limited (HCA 1412/2013)
  • Acted for the minority shareholders in the dispute in relation to China Investment Fund Company Limited (HCA 411/2016)
  • Acted for the majority shareholder in the dispute in relation to Jiang Yuan International Development Limited (HCMP 3166/2014)
  • Acted for CIL Holdings Limited (479.HK) in various disputes (HCA 2900/2001, CACV 11/2015; HCA 2725/2001, CACV 90/2013, FAMV 62/2014)
  • Acted for the majority shareholder in the dispute in relation to ZMFY Automobile Glass Services Limited (8135.HK) (HCMP 3322/2014)
  • Acted for the majority shareholders in the disputes in relation to China Sales Group Limited (HCMP 616/2017, HCMP 116/2018)
  • Sinoearn International Ltd v Hyundai-CCECC Joint Venture (a firm) [2012] 1 HKLRD 823;



  • Acted for the investor in a cross-border Option Agreement dispute (UNCITRAL HK)
  • Acted for the US technology contributor in a contractual dispute with the stated-owned PRC joint venture partner (ad hoc HK)
  • Acted for the HK authorised dealer in a contractual dispute with the Macanese distributor (ICC)
  • Acted for a PRC listed company in relation to derivative products investments disputes (HKIAC)
  • Acted for the foreign supplier in relation to contractual disputes with the PRC buyer (CIETAC-HK)
  • Acted for the Chinese distributor and its holding company (listed on HKSE) in relation to contractual dispute with the foreign pharmaceutical products supplier (HKIAC)
  • Acted for the foreign side investor in relation to funding disputes arising from 3 expressway projects in Tianjin Province (HKIAC)



  • Advised on proposed listings on both the Main Board and the GEM Board of the HKSE
  • Acted for the Insurance Agents Registration Board in appeals against its decisions to the Appeals Tribunal
  • Advised the Equal Opportunities Commission on matters of complaints and enforcement